Results 141 to 150 of about 271,602 (230)

Integrating computational thinking into secondary school mathematics teaching: A literature review

open access: yesReview of Education, Volume 14, Issue 1, April 2026.
Abstract Computational thinking (CT) has established itself as a fundamental skill for the 21st century, driving its integration into various disciplines, especially mathematics. This systematic review of the literature aimed to analyse how the integration of CT has been conceptualized and implemented in mathematics teaching in the context of secondary
María Isabel Ruiz Recio   +2 more
wiley   +1 more source

Thank You to Our Peer Reviewers in 2025

open access: yesSpace Weather, Volume 24, Issue 4, April 2026.
Abstract Peer reviewing is the foundation of modern scholarship, with external specialists being asked to fairly check and evaluate submitted work. This difficult and often time‐consuming activity is performed voluntarily, with the understanding that one's own scholarship shall benefit down the line from a careful analysis of its assumption, results ...
Steven K. Morley   +5 more
wiley   +1 more source

Multivariate Gram-Charlier Densities [PDF]

open access: yes
This paper introduces a new family of multivariate distributions based on Gram-Charlier and Edgeworth expansions. This family encompasses many of the univariate seminonparametric densities proposed in the financial econometrics as marginal distributions ...
Del Brio, Esther B.   +2 more
core   +1 more source

Editorial Expression of Concern: Antinociceptive and antiedema effects produced in rats by Brassica oleracea var. italica sprouts involving sulforaphane. [PDF]

open access: yesInflammopharmacology
Guadarrama-Enríquez O   +10 more
europepmc   +1 more source

Economic crisis and democratic consolidation in Spain, 1973-82 [PDF]

open access: yes
This Spain’s transition from dictatorship to democracy after the death of General Francisco Franco in 1975 has been viewed in many ways. Political historians and political scientists generally deem it an outstanding success.
Joseph Harrison
core  

Harnessing iEcology data to uncover invasive species behaviour

open access: yesMethods in Ecology and Evolution, Volume 17, Issue 4, Page 1022-1031, April 2026.
Abstract Invasive animal species threaten ecosystems, biodiversity and human livelihoods. Behavioural traits such as boldness, exploratory tendencies, learning ability and social interactions are known to influence invasion success. Yet these behavioural traits remain underexplored due to challenges in observing behaviour across large spatial and ...
Peter Mikula   +22 more
wiley   +1 more source

Thank You to Our 2025 Peer Reviewers

open access: yes
AGU Advances, Volume 7, Issue 2, April 2026.
Alberto Montanari   +23 more
wiley   +2 more sources

A Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report

open access: yesAllergy, Volume 81, Issue 4, Page 1024-1038, April 2026.
ABSTRACT The European Academy of Allergy and Clinical Immunology (EAACI) established a Task Force to assess the existing data on the relationship between eosinophilic esophagitis (EoE) and allergen immunotherapy (AIT). This systematic review and meta‐analysis aimed to study the incidence of confirmed EoE, developing as a side effect of AIT to food or ...
Carlo Maria Rossi   +14 more
wiley   +1 more source

Ventral hernia containing a term gravid uterus: A rare challenge in surgical and obstetric management. [PDF]

open access: yesRadiol Case Rep
Zepeda Torres JM   +10 more
europepmc   +1 more source

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.
In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.
Marco Sanduzzi‐Zamparelli   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy